Baxter International, a leading global healthcare company, has officially named Andrew Hider as its next Chief Executive Officer. The announcement marks a significant leadership transition for the Illinois-based medical products giant. Hider, who currently serves as CEO of ATS Corporation, will take the reins at Baxter beginning July 15, 2025, succeeding José Almeida, who has served as Baxter’s Chairman and CEO since 2016.
This move is part of a broader strategic plan as Baxter reshapes its focus and prepares for long-term growth. The appointment of Andrew Hider as Baxter CEO has sparked interest across the healthcare and business communities, given Hider’s track record of transformation and operational excellence.
Andrew Hider is no stranger to leading large, complex organizations. He has been the Chief Executive Officer of ATS Corporation since 2017. ATS is a global automation solutions provider catering to life sciences, food and beverage, transportation, and consumer markets. Under Hider’s leadership, the company experienced consistent growth, expansion into new global markets, and a strong focus on innovation.
Before joining ATS, Hider held various leadership positions at Textron Inc., Danaher Corporation, and other industrial technology firms. His background combines operational know-how, business transformation skills, and a focus on results — qualities that align well with Baxter’s ambitions.
Hider holds a Bachelor’s degree in Business Administration from Bowling Green State University and an MBA from the University of Dayton. His career spans more than 25 years, with deep experience in scaling businesses, strategic execution, and digital transformation.
Baxter’s decision to appoint Andrew Hider as CEO comes at a critical time. Over the past several years, Baxter has been undergoing a transformation to streamline operations, focus on high-growth areas, and improve profitability. According to the company’s board of directors, Hider brings the kind of forward-thinking leadership needed for Baxter’s next chapter.
José Almeida, who will remain executive chairman of the board through 2025, expressed confidence in the transition. “Andrew is a transformative leader. His focus on innovation, operational discipline, and customer-centricity aligns perfectly with Baxter’s strategic goals,” Almeida said in a press release.
The healthcare industry is evolving rapidly due to digital technologies, regulatory pressures, and growing demand for patient-centric care. Baxter has long been a leader in providing critical care, renal therapies, infusion systems, and surgical products globally. With Andrew Hider stepping in as CEO, the company is signaling a stronger emphasis on innovation and global execution.
Here are some of the changes we may expect:
Given Hider’s background in industrial automation, he’s expected to bring efficiency-driven strategies to Baxter’s manufacturing and supply chain systems.
Hider has consistently invested in R&D at ATS. Industry analysts believe Baxter may increase its focus on new product development and medical device innovation under his leadership.
ATS grew its global footprint significantly under Hider. Baxter, which already operates in over 100 countries, could see renewed energy toward penetrating emerging markets.
Hider is known for building high-performing teams. His appointment could bring a cultural shift toward agility, accountability, and innovation within Baxter.
The healthcare industry and investor community have largely responded positively to the appointment. Shares of Baxter rose slightly following the announcement, reflecting market optimism about the change.
J.P. Morgan analysts noted that Hider’s cross-industry experience brings a fresh perspective, which could help Baxter differentiate itself in an increasingly competitive landscape.
Healthcare consultant Linda Barrett commented:
“This is a bold and smart move. Baxter is clearly preparing for a new phase of digital and operational excellence. Andrew Hider’s leadership could unlock significant long-term value.”
The transition also marks the end of an important era. José Almeida, who led Baxter for nearly a decade, was instrumental in stabilizing and growing the company during challenging times. His achievements include:
Though he will remain on the board during the transition period, Almeida’s day-to-day leadership will officially conclude with Hider’s arrival.
Here’s what the key players had to say about the leadership change:
“It is a great honor to join Baxter, a company with such a rich legacy in healthcare. I look forward to working with the talented team to shape a strong and innovative future for patients, healthcare providers, and shareholders around the world.”
“I’m proud of what we’ve built over the years. Andrew’s leadership, vision, and integrity make him the ideal person to lead Baxter into its next era.”
With Hider’s appointment, Baxter stakeholders can expect a few key shifts:
Analysts are keeping an eye on how Hider’s industrial-tech background translates to Baxter’s healthcare-driven operations. But given the convergence between healthcare and automation, the fit appears promising.
The appointment of Andrew Hider as Baxter CEO represents more than just a routine leadership change. It is a calculated move to bring in a transformative leader with a strong operational background and a proven record of driving growth in complex industries.
As Baxter continues to innovate in the fields of critical care, renal therapies, and surgical products, Hider’s leadership could be the key to unlocking new levels of performance and global reach.
With strong support from the board and the outgoing CEO, the company appears well-positioned for this next phase. All eyes are now on how Andrew Hider will shape Baxter’s future — and how quickly his vision will turn into results.
Read Next – KKR Assura Takeover Bid Fails as Shareholders Reject $2.32 Billion Offer
Pursuing a Master’s in the United States is a dream for students worldwide, especially in…
When the government proposes a major new spending bill, the public often hears only the…
Studying abroad remains a dream for many students looking for global exposure, advanced education, and…
As rising health insurance costs continue to shake the U.S. healthcare industry, insurers are facing…
Wilmington, Delaware may be a small city, but it’s full of charm, history, and vibrant…
Porsche deliveries fall in the first half of 2025, as the German luxury carmaker struggles…